OFFICE OF FISCAL ANALYSIS
Legislative Office Building, Room 5200
Hartford, CT 06106 (860) 240-0200
http://www.cga.ct.gov/ofa
SB-1003
AN ACT PROHIBITING CERTAIN HEALTH CARRIERS AND
PHARMACY BENEFITS MANAGERS FROM EMPLOYING COPAY
ACCUMULATOR PROGRAMS.
AMENDMENT
LCO No.: 8736
File Copy No.: 363
House Calendar No.: 448
Senate Calendar No.: 230
Primary Analyst: AN 5/18/21
Contributing Analyst(s): (NF)
OFA Fiscal Note
No Fiscal Impact
There is no fiscal impact resulting from the amendment, which
prohibits drug manufacturers from providing coupons for brand name
prescription drugs to individuals unless there is no generic drug
equivalent.
The preceding Fiscal Impact statement is prepared for the benefit of the members of the General Assembly, solely
for the purposes of information, summarization and explanation and does not represent the intent of the General
Assembly or either chamber thereof for any purpose. In general, fiscal impacts are based upon a variety of
informational sources, including the analyst’s professional knowledge. Whenever applicable, agency data is
consulted as part of the analysis, however final products do not necessarily reflect an assessment from any
specific department.